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The study on Gram- positive and Gram-negative bacteria by Kohanksi et al. 
(2007) challenged the longstanding notion about antibiotic induced cell death. 
The authors showed that these bacteria illustrate a common death pathway 
when exposed to fluoroquinolones, aminoglycosides and β-lactams. Cell 
death, they show, is caused by the production of hydroxyl radicals via the fen-
ton reaction. To determine whether the same pathway is triggered in the evolu-
tionary distinct Mycobacteria, studies were conducted with the fast growing 
workhorse model organism, M. smegmatis. Upon adapting the protocol de-
scribed in Kohanski (2008), it was found that we could measure hydroxyl rad-
icals in M. smegmatis generated by H2O2. We show that fluoroquinolones pro-
duce hydroxyl radicals, and that the quenching of these radicals resulted in in-
creased bacterial survival indicating their involvement in causing cell death. 
Three other drugs which are used in Tb therapy, isoniazid, kanamycin and 
ethambutol were also tested. However, none of them significantly induced hy-
droxyl radicals. These results suggest that, in contrast to other bacteria,       
mycobacteria harbor hydroxyl radical dependent as well as independent cell 
death pathways. This study serves as a foundation to further our knowledge 
about pathways triggering reactive oxygen species and how we could use them 
to identify new targets for drug discovery. If such a pathway is activated in M. 
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1. Introduction     
 
The number of these Animals in the scurf of a man’s teeth are so many that I 
believe they exceed the number of Men in a kingdom. For upon the examina-
tion of a small parcel of it, no thicker than a Horse-hair, I found too many liv-
ing Animals therein, that I guess there might have been 1000 in a quantity of 
matter no bigger than the 1/100 part of sand.  
                                                         —Anton Van Leeuwenhoek, 1684 
300 years ago, Anton Van Leeuwenhoek developed the first prototype of to-
day’s microscope and observed for the first time, life invisible to the naked 
eye. Now we know that these organisms are all around us in teeming millions, 
and it is their presence (if you call a company of a million or more cells- pres-
ence!) that keeps the food chain alive. They are our evolutionary ancestors, 
and we believe that learning about these unicellular creatures would help an-
swer so many of our questions about life. After all, they have been here for a 
couple of billion years!  
Studying them has helped us lay down some rules that govern life and surviv-
al. Laws of nature, we’ve learnt, allow only conditional proliferation of organ-
isms. All forms of life require certain conditions, both internal and external, to 
live and proliferate. Food, space and environment play an important role in 
survival. Even oxygen, a life nurturing chemical could be toxic for survival. 
While anaerobes cease to thrive in the presence of oxygen, aerobes can toler-
ate oxygen only up to particular threshold concentrations. Aerobes, however, 
employ antioxidants that can nullify oxygen species that are formed in high 
oxygen concentrations (Imlay, 2003). Understanding this phenomenon of en-
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vironment induced cell death, has been a fascinating study for evolutionary 
biologists and microbiologists due to the ease of experimenting with micro-
organisms and for the wealth of evolutionary history we uncover by studying 
them. 
 Some of these micro-organisms, however, -inadvertently as a part of their life 
cycle- are harmful to us. They can cause serious illnesses that shut down our 
immune defense mechanisms, eventually leading us to death. We have used 
our knowledge about them and turned it against them. By means of antibiotics, 
we are able to create inhospitable conditions for their survival and ‘induce mi-
crobial death’. Scientists have, since its miraculous discovery, probed into 
mechanisms of antibiotic action. The idea of this is to manufacture more of 
these substances and ward off threats to human health. Antibiotic induced 
cell death has been an area of commercial, intellectual, and scientific interest. 
 
Studying cell death mechanisms has noticed accentuated interest, especially in 
the face of the emerging antibiotic resistance. Bacteria are constantly reinvent-
ing themselves to escape antibiotic mediated damage/death. The existing anti-
biotic weaponry is failing us, and we are once again thrust into a war against 
these bugs.  Before the pre-antibiotic world becomes today’s reality, we must 
find ways to combat them. Thus, reverting back to studying basic bacterial bi-
ology and understanding mechanisms of cell survival and cell death seems 
more fitting now, than ever. 
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1.1   Cellular environment induced death 
  
Reactive oxygen species mediated cell death. 
 
Aerobic organisms require oxygen for respiration and driving their cellular 
activity; unlike anaerobes that fail to survive in oxygenated environments. 
However hyperoxia, a condition of excess oxygen, is harmful even to aerobes 
(Imlay, 2003). In order to protect themselves from the effects of hyperoxia, 
microorganisms harbour antioxidants such as glutathione, ascorbic acid and β-
carotene (Cabiscol, Tamarit, & Ros, 2000) along with enzymes Superoxide 
dismutase and Catalase to nullify the effects of reactive oxygen species such 
as the superoxides and peroxides (Carlioz & Touati, 1986; Messner & Imlay, 
1999; Rorth & Jensen, 1967).  
How are these reactive oxygen species formed? 
Superoxides and peroxides are reactive species formed during respiratory en-
zyme turn over. The enzymes of the TCA cycle, such as the dehydrogenases, 
utilise flavin co factors to accept hydride anions. The reduced flavins, in turn 
donate their electrons to secondary redox moieties such as iron sulphur clus-
ters. During electron transfer, if molecular oxygen inadvertently collides with 
the co-factor, oxygen gets reduced to superoxide and a flavosemiquinone is 
generated. The superoxide leaves the active site permitting a reaction between 
the flavosemiquinone and a second molecule of O2 to generate another super-
oxide. However during collision, there is a possibility of spin inversion of 
electrons in the flavosemiquinone or superoxide resulting in a peroxy adduct. 
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Heterolytic cleavage of this bond releases hydrogen peroxide (Messner & 
Imlay, 1999).  
 
 
Figure 1: Generation of superoxides and peroxides during respiration. Adapted 
from Imlay,2003. 
   
Thus the autooxidation of flavoenzymes yields a mixture of peroxide and su-
peroxide (Massey, 1994). The rate at which superoxides and peroxides are 
formed depends on the frequency of collisions with oxygen (Messner & Imlay, 
1999, 2002). The production of superoxide and hydrogen peroxide affects var-
ious cellular processes. Both of them, for instance damage iron-sulphur clus-
ters present in the pockets of dehydrogenase enzymes (Flint, Tuminello, & 
Emptage, 1993). The damage releases catalytic iron, and deactivates the en-
zyme. The free iron released can participate in the fenton reaction, and pro-







The fenton reaction is driven by iron in the presence of hydrogen peroxide to 
produce hydroxyl radicals (Aslund, Zheng, Beckwith, & Storz, 1999). 
Fe 
2+
+H2O2           Fe 
3+ + OH ˙ + OH ¯   
The free iron pool in bacteria contains iron released from the destruction of 
iron sulphur clusters (Keyer & Imlay, 1996), iron that has escaped trafficking 
process and iron that is formed by the spontaneous de-metallation of enzymes 
such as the aconitases (Varghese, Tang, & Imlay, 2003). Free iron, is often 
found bound to the surfaces of certain cellular biomolecules and DNA, making 
them a favourable target for fenton mediated damage (Rai, Cole, Wemmer, & 
Linn, 2001).     
Why are hydroxyl radicals so deleterious? 
The molecular orbital structures of the oxygen species determine their reactivi-
ty. The anionic charge on superoxide makes it a poor acceptor of electrons 
from electron rich molecules, while the stable oxygen-oxygen bond in H2O2 
makes it less reactive. Hydroxyl radicals, on the other hand, encounter no hin-
drance (Imlay, 2003). With a half life of nanoseconds (Sies, 1993), they eager-
ly react with all molecules at diffusion limited rates,  making them the most 
deleterious of all reactive oxygen species (Imlay, 2003). 
Hydroxyl radicals are products of the fenton reaction. Once they are produced, 
they instantly oxidize the molecules they encounter. They are often linked to  
protein oxidation (Liochev & Fridovich, 1994), lipid peroxidation (Bielski, 
Arudi, & Sutherland, 1983),  besides causing DNA damage.  
Hydroxyl radicals can also be produced when free Cu
2+
 reacts with hydrogen 





 is low and the available Cu
2+
 is often bound to thiols (Gunther, 
Hanna, Mason, & Cohen, 1995).  
 
Oxygen toxicity is an unplanned consequence of aerobic respiration. Cells are 
constantly exposed to ROS and their effects are annulled by ROS scavenging 
enzymes.  This explains why these enzymes are found in higher numbers in 
aerobes than in anaerobes (McCord, Keele, & Fridovich, 1971). However, if 
the amount of ROS formed exceeds the capacity of the scavenging enzymes, 
extensive damage could occur to the cell that could lead to cellular death.
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1.2  Antibiotic induced cell death 
 
The serendipitous discovery of penicillin by Alexander Fleming changed the 
course of anti-microbial therapy. Over the past 7 decades, we have a consorti-
um of naturally derived, synthetic and semi-synthetic antibiotics that handicap 
bacteria of specific biochemical/ molecular processes. The absence of these 
processes either kills or stunts bacterial growth. These antibiotics broadly fall 
into 3 classes depending on their target: 
 Antibiotics that disrupt transcription and/or translation. 
 Antibiotics that target cell wall. 
 Antibiotics that target the DNA/ DNA replication enzymes (Walsh, 
2000). 
 
Antibiotics that inhibit of transcription: 
Transcription is a process by which information on the DNA is complemen-
tarily transcribed into mRNA by RNA polymerase. The messenger RNA con-
tains the message required to manufacture the required protein. 
 Eubacterial RNA polymerase has 4 units: 1 units, 1 unit, 1’unit and 1 
units (Yura & Ishihama, 1979). The four units are important for the progres-
sion of the polymerase through the double stranded helix. Since this process is 
important for protein production, we have antibiotics that specifically target 
this process in bacteria. Rifampicin, a broad spectrum antibiotic used in first 





Rifampicin belongs to the class of rifamycins isolated from bacteria, 
Norcardia mediterranae.  
Rifampicin specifically interferes with eubacterial transcription by interacting 
with the  subunit of the RNA polymerase. Studies indicate that the binding 
prevents the exit of the newly synthesized mRNA from the catalytic core of 
the enzyme, preventing chain elongation beyond 2-3 nucleotides. This produc-
es short segments of useless mRNA, and indirectly halts protein synthesis 
(Campbell et al., 2001). 
 
Antibiotics that inhibit translation: 
Translation is the process by which the transcribed mRNA forms a functional 
protein. Translation is a highly proofread process to ensure that only function-
al proteins exit the translational machinery. Classes of antibiotics known as the 
aminoglycosides are extensively used to hinder bacterial protein synthesis. 
 
Aminoglycosides 
Aminoglycosides are a group of ribosome inhibitors that interfere with protein     
translation. During translation, the aminoacylated tRNA with an anticodon and 
a corresponding amino acid enters the ribosomal decoding site (A-site). Two 
nucleotides A1492 and A1493 on the rRNA flip out of their native confor-
mations to assess Watson-Crick base pairing between incoming codon and the 
codon on the mRNA. Aminoglycosides such as paromycin bind and stabilize 
this conformation (flipped-out conformation) even if the base pair geometry is 
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not obeyed. This leads to the erroneous elongation of the polypeptide chain 
(Stanley, Blaha, Grodzicki, Strickler, & Steitz, 2010).  
 Some mistranslated proteins produced by the binding of these antibiotics end 
up as membrane proteins. This disturbs the integrity of the cell wall, and pro-
motes further antibiotic uptake that leads to cell death (Melancon, Tapprich, & 
Brakier-Gingras, 1992). 
 
Antibiotics that target the cell wall:   
Bacterial cell wall is composed of peptidoglycan. Peptidoglycan precursors, 
N-acetyl muramic acid (NAM) and N-acetyl glucosamine (NAG) are synthe-
sized in the cytosol and loaded on to a carrier protein, bactoprenol. 
Transglycosylation enzymes catalyze the transfer of the precursors to existing 
polypeptide chains, while transpeptidases help in cross-linking. 
Transpeptidases and transglycosylases are called penicillin-binding proteins. 
Β-lactams are examples of some frequently applied cell-wall inhibitors 
 
β-lactams  
 β-lactams weaken cell wall by inactivating penicillin-binding proteins in-
volved in cell wall synthesis. Transpeptidases bind to the D-alanine residues 
on the NAM unit and cross-link the peptidoglycan precursors with the existing 
units. β-lactams contain terminal alanine residues, and thus structurally mimic 
the substrate of the enzyme. By irreversible binding, β-lactams acylate the en-






Mycolyl-arabinogalactan peptidoglycan inhibitors: 
Cell wall core of mycobacteria consists of Mycolyl-arabinogalactan pepti-
doglycan (MAP) layer between the plasma membrane and the lipid rich cap-
sule. The peptidoglycan layer in mycobacteria is supposed to be similar to that 
in E. coli with variations in the degree of cross-linking (Matsuhashi, 1966). 
The peptidoglycan backbone is covalently bonded to arabinogalactan chains 
while the terminal units of the arabinogalactan are esterified to Mycolic acids 
(Crick, Mahapatra, & Brennan, 2001). Various other soluble free lipids and 
glycolipids also attach themselves to the cell wall, further strengthening it. 
This unique cell wall of Mycobacteria poses as an ideal target for drugs.  Thus, 
two of the four first line drugs (isoniazid and ethambutol) used in tuberculosis 
treatment are Mycobacterium cell wall inhibitors. 
 
Isoniazid (INH) 
Isoniazid inhibits mycolic acid synthesis.  
The Fatty acid synthase II (FAS II) system is involved in the synthesis of  long 
chained -alkyl -hydroxy fatty acids called mycolic acids.(Winder & Collins, 
1970). NADH dependent enoyl ACP reductase (INH A) is an important en-
zyme in the FAS system (Marrakchi, Laneelle, & Quemard, 2000). 
                  INH is a prodrug that enters the cell through passive diffusion and 
requires activation by Kat-G once inside the cell (Middlebrook, 1954). Kat-G 
mainly has a catalase activity but also performs other functions. Upon activa-
tion, the drug interacts with NAD and forms a stable covalent bond 
(Rozwarski, Grant, Barton, Jacobs, & Sacchettini, 1998). It was later found 
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that the activated drug formed a hypothetical isonicotinoyl radical and links in 
a covalent bond with NAD(Vilcheze & Jacobs, 2007). The resulting adduct 
inhibits INH A activity thereby interrupting mycolic acid synthesis (Lei, Wei, 
& Tu, 2000).    
 
Ethambutol 
Ethambutol also inhibits mycobacterial cell wall synthesis.  
Mycolic acids attach to the 5’-hydroxyl groups of D-arabinose residues of the 
arabinogalactan to form the Mycolyl-arabinogalactan peptidoglycan cell wall. 
Arabinosyl transferases transfer arabinose residues to form glycosidic linkages 
with D-galactan. Ethambutol is a specific inhibitor of the arabinosyl transfer-
ases, thus preventing the formation of cell wall (Takayama & Kilburn, 1989). 
 
Antibiotics that interact with DNA modifying enzymes 
DNA contains all the information required for the survival of an organism, and 
it undergoes several orders of compaction to fit inside a cell. However, for es-
sential cellular process such as replication, transcription or repair, relaxation of 
the supercoiled DNA is necessary so that the information can be ‘read’ and 
deciphered. Enzymes known as DNA topoisomerases perform the function of 
inducing negative-supercoiling by cutting one or both strands of DNA, and 
rejoining them such that the number of helices is reduced by a certain factor. 
After the execution of the cellular activity, the original supercoiling is re-
stored.  The most celebrated class of DNA inhibitors are the fluoroquinolones. 





Fluoroquinolones are class II topoisomerase inhibitors. Class II topoisomeras-
es include gyrase and topoisomerase IV. 
Gyrase induces negative supercoils by cutting one of the strands of DNA, 
passing the other strand of DNA through the nick, and later rejoining the cut 
DNA. This relaxes the highly coiled DNA allowing cellular processes to con-
tinue.  
Topoisomerase-IV, on the other hand, is involved in de-catenation of DNA 
strands during circular DNA replication. The two circular DNAs get inter-
coiled once replication ends. Topoisomerase IV, cuts one helix, and allows the 
other to pass through, thus unlinking them. Both Gyrase and topoisomerase IV 
act in an ATP dependent manner (Drlica & Zhao, 1997; Roca, 1995).                                                                                                                   
Fluoroquinolones bind to the topoisomerase-cleaved DNA complex. Upon 
stabilization of the enzyme-cleaved DNA-drug complex, a number of double 
strand breaks occur, causing irreversible DNA damage and cell death (Peng & 
Marians, 1993; Snyder & Drlica, 1979). 
 
The decade that followed the discovery of penicillin saw a boom in antibiotic 
development. However, the mode of action of any of the antibiotics discovered 
was not determined until the rapid technological advancement in the later half 
of the 20
th
 century, and at the turn of the 21
th
 century. Today, the atomic level 
precision of drug-target interactions is mostly obtained by Nuclear magnetic 
resonance and X-ray crystallographic studies along with supporting biochem-
ical and molecular biology studies. However, these studies cannot predict the 
events succeeding the interaction. That still remains a black box.  
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1.3  The common death pathway- Going against the dogma  
                                                                                                   
The accumulated intelligence of over 3 billion years of life on earth has ena-
bled bacteria to persist and proliferate. Over time, earth has changed drastical-
ly and these organisms have constantly reinvented themselves and adapted to 
the changing environment. So in a way, we must have foreseen that in due 
time bacteria would adapt to the conditions we force on them by means of an-
tibiotics and evade their negative effects. 
Bacteria evade antibiotics by: 
 Acquiring mutations at the site of drug binding 
 Producing enzymes that inactivate the drug 
 Altering drug permeability 
  Employing efflux pumps 
 Utilizing another pathway to produce the inhibited metabolic product 
(Walsh, 2000).  
Though inevitable in a way that antibiotic resistance should occur, misuse 
of antibiotics has fastened the pace of evolution of resistance (Carey & Cryan, 
2003). Thus in order to solve this burgeoning problem of resistance, we need 
to understand the basics of bacteriology and re-lay its foundations brick by 
brick. A better understanding of bacteria is important and crucial to avoid the 
relapse of this problem. 
One such team in the US, aiming to understand basic bacteriology and cell 
death pathways, have uncovered some facts that has shaken the foundation of 
cell death biology. 
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  In 2007, Kohanski and colleagues published their findings on cellular death 
pathways traced by gram-positive and gram-negative bacteria when exposed 
to antibiotics. The questions they were looking to answer through the study 
were different from the conventional ones. They approached cellular death 
pathways using a magnifying glass to answer the following questions..     
How do all antibiotics after initial interaction with the target cause cell dam-
age? Is there more happening than we know?  
And most importantly, do they activate same pathways to eventually cause 
bacterial cell damage? 
While we do have a grasp of the basics of antibiotic action, we are yet una-
ware of what goes on downstream of primary drug-target interaction (Lewis, 
2000). The study by Kohanski and colleagues showed that bactericidal drugs, 
in the three main classes of aminoglycosides, B-lactams and fluoroquinolones 
activate a common pathway to result in reactive oxygen species mediated cell 
death. This by essence means that, some antibiotics induce a high oxygen en-
vironment in the bacterial cell to result in cell death, therby linking the two 
modes of cell death discussed earlier- truly revolutionary!  
The pathway they propose is activated upon drug-target interaction. This in-
teraction, they found, upregulated genes in the TCA cycle, (as indicated by 
gene expression and molecular biology studies) and resulted in a hyperactive 
respiratory chain. The superoxides, products of increased respiration, damage 
the iron-sulphur clusters in the pockets of the dehydrogenase enzymes. The 
damaged clusters released free iron that participated in the fenton reaction and 













In order to trace this pathway, they used hydroxyl radicals as a prime indicator 
of the activation of this pathway. They use Hydroxy Phenyl Fluorscein (HPF), 
a fluoroscent probe to detect hydroxyl radicals via flow cytometry. HPF is a 
hydroxyl radical specific fluorescent probe that gets oxidised on interacting 
with hydroxyl radicals, and gives out a bright green fluorescent signal 
(Setsukinai, Urano, Kakinuma, Majima, & Nagano, 2003).  In order to prove 
for the specificity of the dye and supplement for the activation of this pathway, 
Kohanski and colleagues use suitable inhibitors of the fenton reaction and 
tested for the dye signal. Applying radical quenchers and iron chelators are 
established means of inhibiting the fenton reaction (Novogrodsky, Ravid, 
Rubin, & Stenzel, 1982). Thiourea, a hydroxyl radical quencher and dypridyl, 
an iron chelator were independently added to drug treated cultures and then 
the cultures were assessed for hydroxyl radicals. The results showed a de-
crease in dye fluorescence upon inhibitor addition.  
These results were strengthened by their gene-expression studies and molecu-
lar biology studies that indicated the involvement of TCA cycle genes and the 
inactivation of iron sulphur clusters. Furthermore, they also found the activa-
tion of SOS response and DNA damage in cells treated with cidal drugs. Inter-
estingly, however, they found that bacteriostatic drugs failed to activate this 
pathway, thus showing that this pathway is instrumental in causing hydroxyl 
radical mediated cell death, and that this pathway is not used by antibiotics 
that (only) inhibit bacterial growth (M. A. Kohanski, Dwyer, Hayete, 
Lawrence, & Collins, 2007). 
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Kohanksy and colleagues use flow cytometry to determine hydroxyl radical 
production. The section below provides an overview of flow cytometry. 
 
1.3.1 Flow cytometry 
Flow cytometry is a new age technology that allows the measurement of mul-
tiple characteristics of cells in a fluid stream, by tagging cells with a required 
fluorescent probe. Multiple characteristics include relative size, complexity 
and fluorescence intensity. The machine records the scattering of incident la-
ser light to measure cellular characteristics. 
Flow cytometry has revolutionized immunology and microbiology. The rela-
tive simplicity in tagging cells with dyes, and analysing thousands of cells 
within minutes with precision has given it an advantage over old-school tech-
niques. This technology also allows us to venture into fields that were earlier 
impossible, and master some existing ones. Analysing heterogenous popula-
tions and detecting contaminants, conducting cell viability studies or capturing 
reactive oxygen/nitrogen studies within its half life of one millionth of a se-
cond, hasn’t been easier. Thus, its widely used in clinical and research set-
tings. 
 
How does it work? 
Flow cytometry uses a fluidics system to enable single cell passage, and an 
optics system to analyse individual cells as they pass through the laser. The 





In order to ensure that at each point, lasers interact with only single cells, hy-
drodynamic focussing is introduced. Hydrodynamic focussing allows the 
sample to pass through a sample core within a sheath fluid. The pressure with 
which the sample passes through can be controlled by the user. The user has to 
determine optimum sample pressure such that only single cells to pass 
through. A high flow rate allows qualitative measurements, while low flow 
rates are preferred for quantitative measurements. 
The optics system is coupled with the electronics system to allow simultane-
ous cell analysis and conversion into readable data. As the cell encounters the 
laser, the light scattered by the cell is captured by the detectors. This depends 
on the cell size, shape and complexity. Forward scatter, is the direct measure-
ment of the size of the particle, and is captured by the detector placed in the 
axis of the incoming laser light. Side scatter measures the light scattered by the 
cell due to the change in refractive index when the laser encounters the inter-
nal constituents of the cell. Side scatter is measured at an angle of 90° to the 
incoming laser. Measuring cell size and complexity is essential in determining 
the physical characteristics of the sample.  
However, the intrinsic value of cytometry is the capturing of light emitted by 
decelerating fluorophores. Fluorescent compounds tagged to cell components 
get excited when exposed to a particular wavelength of light. The excited elec-
trons jump to higher energy levels, and upon decaying back to its ground state, 
emit photons of lights which are captured by detectors. The lasers required to 
be installed in a flow cytometer depends on the absorption/ emission spec-
trums of the fluorophores used. Often, more than one fluorophore is used such 
that their emission spectrums do not overlap.  
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Detectors are installed in the cytometer to detect the light. Photomultiplier 
tubes are placed in front of detector, to ensure only specific wavelengths of 
light can pass through, thus increasing detection specificity. The detectors 
convert light signals into voltage pulses which are later assigned channel 
numbers in data plots by ADC converters. On a data plot, each dot denotes a 
cell and the dots are positioned according to its fluorescence intensity.    
Since, most often, heterogeneous populations are analysed by flow cytometry, 
it is important to gate the cells. Gating in flow cytometry ‘language’ refers to 
the choosing of cell population for analysis. This is done based upon the re-
quired cell size, complexity and fluorescence or a combination of all three 
(BD Biosciences, 2000, p5-30).  
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1.4   Mycobacteria- Do they show the common pathway? 
 
Mycobacteria are an evolutionary distinct subgroup of bacteria, characterized 
by their rich mycolic acid cell wall and G-C rich genetic material. They are 
gram positive –acid-fast bacteria, rod shaped in structure. Though most spe-
cies in this genus are found in the environment existing as saprophytes, some 
of them are known to cause serious life threatening diseases such as leprosy, 
buruli ulcer and tuberculosis (Long et al., 2012). 
Mycobacterium tuberculosis 
Mycobacterium tuberculosis is a respiratory pathogen that causes severe air-
borne infections. The disease is caused by the active pathogen infecting the 
lungs. Once the pathogen enters the lungs, it resides (prominently) in macro-
phages, neutophils, monocytes and dendritic cells (Wolf et al., 2007) and uses 
various virulence mechanisms such as the ESX1 type VII secretion system to 
spread from cell to cell. (This secretion system promotes the death of infected 
phagocytes and promotes the recruitment of new phagocytes. Thus, bacteria 
released from the now-dead phagocytic cells infect the newly enlisted ones, 
thereby increasing the infection(Pym, Brodin, Brosch, Huerre, & Cole, 2002 )) 
Though innate immune responses are initiated upon infection, there is little or 
no effect on the growing bacteria (Ernst, 2012). The bacterium nullifies host 
innate immune responses and simultaneously prevents host cell apoptosis 
(Pym, Brodin, Brosch, Huerre, & Cole, 2002; Velmurugan et al., 2007). An-
other characteristic feature of Tb infection is the delay in the onset of adaptive 
immune response. Though the adaptive immune response upon initiation im-
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pedes bacterial growth, it drives the bacteria into a state of dormancy (Poulsen, 
1950). In this state of dormancy, the bacteria slowly form tuberculi or nodules 
that eventually calcify (Woodring et al., 1986). The calciferous nodules pre-
vent blood supply to the lungs, thereby impeding the normal function of the 
respiratory and circulatory system. While studies attribute the reactivation of 
dormant bacteria to the degeneration of the body to sub-competent or incom-
petent immune systems (Ernst, 2012), some studies indicate that a decreased 
CD4
+
T cell count due to HIV co- infection (Geldmacher et al., 2010) and med-
ical conditions such as diabetes (Harries et al., 2011) as other contributors to 
the resurgence of the bacteria.  The reactivated pathogen causes symptomatic 
disease which is infectious.    
WHO estimates that at a given time, about 1/3
rd
 of the world is infected with 
the bacterium (WHO, 2010). We may assume temporary relief that only the 
active form of the disease is contagious, but an extended cause of concern is 
the now-consistent failure of Tb drug-bank against the active pathogen. The 
major contributor to the failure of our drug-system is the emergence of persis-
tent and drug-resistant bacilli. Persistent bacilli are not genetically resistant to 
the drug, but they may employ mechanisms to evade the drug by assuming a 
physiological state that renders drug-therapy useless. Low oxygen or carbon 
environments could also urge sub-populations to turn persistent. Resistant ba-
cilli, on the other hand, inherit their ‘resistant traits’. The inherited genetically 
modified genes in these bugs  make them nonchalant to drug therapy 
(Sacchettini, Rubin, & Freundlich, 2008). Though strains that are resistant to 
one drug are still treatable, multidrug and extremely drug resistant strains 
make drug therapy ineffectual. While multi-drug resistant (MDR) strains are 
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resistant to the two key first line drugs isoniazid and rifampicin (Kochi, 
Vareldzis, & Styblo, 1993), extremely drug resistant (XDR) strains are MDR 
strains that are also resistant to the second line fluoroquinolones and the in-
jectable aminoglycosides (Berry & Kon, 2009). Treating MDR and XDR 
strains extends Tb therapy to 2 years with slim possibilities of recovery with 
the existing Tb drug-bank. All of this combined with the increasingly mobile 
world has accelerated concerns of the spreading of this disease.   
In such as scenario, adopting Kohanski et al.’s approach to identify antibiotic 
induced cell death pathways seems very interesting, and enticing. If the com-
mon death pathway shown in gram-positive and gram-negative bacteria holds 
true for Mycobacteria, the implications would be enormous. This pathway 
would eliminate the need of multiple targets to kill bacteria, and instead steer 
the direction of drug discovery towards identifying suitable molecular/ genetic 
target in this pathway. These drugs could be used in parallel treatments with 
our existing antibiotics to compromise bacterial oxidative defences (Sies, 
1993).  
Thus, the idea of this study was to determine if Mycobacteria behave similar 
to E. coli and S. aureus when exposed to antibiotics. Here, we use Mycobacte-
rium smegmatis, a fast growing mycobacterial surrogate as a model for con-
ducting preliminary studies. 
Why use M. smegmatis as the model organism? 
M. smegmatis is non-pathogenic organism. The bacterium follows a sapro-
phytic existence in our environment.   
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M. smegmatis shares some homologous genes with its pathogenic cousins. Al-
so, M.tb and M. smegmatis share conserved transcriptional machinery, sigma 
factors and two-component systems (French, 2006). 
Furthermore, M. smegmatis has a short generation time of 3-4 hours making it 
researcher-friendly!  
In a nutshell, the ease of genetic manipulation coupled with its fast growing 
and non-pathogenic nature makes M. smegmatis an ideal workhorse model for 
mycobacterial studies (French, 2006). 
 
Goals and Objectives 
The prime question that we posed in this study was  
Do mycobacteria produce hydroxyl radicals in response to antibiotic treat-
ment?  
To determine this,  
 We used the hydroxyl radical specific fluorescent probe Hydroxy Phe-
nyl Fluorscein (HPF) to detect hydroxyl radicals in antibiotic treated 
cultures of M. smegmatis by means of flow cytometry.   
 Fenton reaction inhibitors, thiourea (hydroxyl radical quencher) and 
dypridyl (iron chelator) were used to inhibit the hydroxyl radical pro-
duction and assess fluorescent probe specificity. 
 These results were co-related with survival to understand if the 
quenching of radicals reduced/prevented cell-death and whether myco-




2.  Materials and methods 
 
2.1   Preparation of basic requirements (growth media) 
 
2.1.1   Preparation of Broth 
Complete 7H9 media was prepared from 7H9 broth media (Difco, 
Middlebrooke).   0.05 % Tween80 (Sigma- Aldrich) and 0.5% (vol/vol) glyc-
erol (Fischer Scientific) were added prior to autoclaving. Autoclaved broth 
was supplemented with 10% (vol/vol) ADC enrichment media (Beckton Dick-
enson). 
 
2.1.2    Preparation of Agar 
Complete 7H10 agar was prepared from 7H10 agar (Difco, Middlebrooke). 
0.5% (vol/vol) glycerol (Fischer Scientific) was added prior to autoclaving. 
10% (vol/vol) OADC enrichment media (Beckton Dickenson) was added to 
the warm agar prior to pouring into plates. 
 
2.2   Bacterial cultures and growth/viability measurements  
Mycobacterium smegmatis mc
2
155 was a gift from A/Prof. Sylvie Alonso, 
NUS. 
 
2.2.1   Preparation of seed stocks 
M. smegmatis mc
2
155 was grown in 7H9 broth media up to an OD of 0.8.  The 
culture was diluted in an equal volume of 50% glycerol (autoclaved) and 










155 was streaked onto an agar plate and incu-
bated at 37C for 2-3 days.  
A single colony of the bacterium was inoculated into 7H9 broth in a PTC 
flask. Every three hours, the optical density of the culture was measured.  
 
2.2.3   Preparation of bacterial cultures and CFU determination                                   
The stocks were thawed and grown in 7H9 growth media to yield a log phase 
growing culture. A 1:25 dilution of M. smegmatis seed stocks was performed 
and incubated at 37C overnight in PTC flasks for all experiments.  
 To determine the colony-forming units (CFU) of bacteria, a serial dilution 
was performed and an appropriate volume of (serially-diluted) culture was 
spread on an agar plate and incubated for 2-3 days.  The colonies were then 
counted and the numbers of colonies were multiplied with the dilution factor 
to give CFU. All graphs for CFU were plotted using Graph Pad Prism 6.  
 
2.3   Determination of MIC/MBC of antibiotics 
Minimum inhibitory concentrations and Minimum bactericidal concentrations 
of the antibiotics were determined. 
 
2.3.1   Preparation of antibiotics: 
Drugs used: ciprofloxacin, sparfloxacin, levofloxacin, ofloxacin isoniazid, 
ethambutol, and kanamycin. All drugs were purchased from Sigma-Aldrich. 
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 The fluoroquinolones were prepared at a concentration of 0.5mM. Kanamy-
cin, isoniazid and ethambutol were prepared at a concentration of 5mM.  
All the antibiotics were dissolved in distilled water. Upon dissolution, the so-
lutions were filter sterilized (0.2µM pore size) and stored at -20C in 1mL 
eppendorf tubes.   
 
2.3.2     Determining the minimum inhibitory concentration  
The MIC used in our study is the visible MIC determined by broth dilution of 
the drugs. 
The drugs were dissolved to a required concentration in 2mL of 7H9 broth in 
15 mL falcon tubes (Beckton,Dickinson). A 1:2 serial dilution was performed.  
Bacterial culture was added to the falcon tubes such that the final optical den-
sity (600nm) was 0.01 and the tubes were then placed on a shaking incubator 
at 37C for 24 hours. After 24 hours, OD600 values were measured. 
 However, prior to measuring the OD, the visible MIC was noted. The concen-
tration of the drug that does not allow any visible growth was noted as the 
MIC. This was determined by observation, and this concentration was applied 
in our study. A no-drug control was included in all our experiments. 
 
2.3.3     Determining the minimum bactericidal concentration  
The MBC was determined based on the MIC. Antibiotics were diluted in 7H9 
broth at MIC, 2xMIC, 4xMIC and 8xMIC concentrations in 15mL falcon 
tubes. Bacterial culture was added to the tubes such that the final optical densi-
ty (600nm) was 0.01. The tubes were placed on a shaking incubator at 37C 
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and after 24 hours, a 1:10 serial dilution of the antibiotic treated cells was per-
formed and the appropriate dilutions were plated on an agar plate.  
The agar plates were incubated at 37C for 2-3 days after which the colonies 
formed on the plate were counted to determine MBC.  
 
2.4    Fluorescence assay: Measuring OH
 
using flow cytometry 
The assay was first optimized using H2O2 (30% (v/v), Merck), a participant in 
the fenton reaction. Further, antibiotics were added to cultures to measure hy-
droxyl radical production. The correct time point for radical measurement in 
H2O2 treated cultures was found to be 3h, while antibiotics produced radicals 
at 24h.  
The protocol followed in the study was as per the protocol stated in Kohanksi 
et al. (2008).  
A 1:50 overnight dilution of M. smegmatis was performed for each experiment 
to yield a starting OD of 0.5-0.6. The cultures were diluted using 7H9 broth to 
an OD of 0.3. 5mL of bacterial suspension was exposed to different concentra-
tion of antibiotics/ H2O2 in PTC flasks. The PTC flasks containing the samples 
were wrapped in aluminium foil, and incubated at 37°C until each time point 
was reached. 
At each time point, 10
6 
cells were collected and added to 500L Phosphate 
Buffer Saline (10X PBS, 1
st
 Base) containing 10M HPF dye (Molecular 
Probes).  The dye treated suspensions were incubated for 15 minutes in the 
dark at 37C. The cells were then centrifuged at 10,000 rpm for 3 minutes and 
the supernatent was removed. Subsequently, the cells were resuspended in 
28 
 
PBS+0.05% tween and added to flow tubes (Beckton, Dickinson) to analyse 
by flow cytometry. 
Atleast 20,000 cells were acquired on Beckman Couter Cyan
TM
 ADP Analyser   
and the data was analysed using Flow jo version 7.6.5. 
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3.  Results 
 
3.1 Determining growth characteristics of M. smegmatis 
A single colony of M. smegmatis was inoculated into 7H9 medium and the 
corresponding growth curves were plotted as shown in Figure 3. Mycobacte-




 Figure 3: Growth curve of Mycobacterium smegmatis. A single colony of M. 
smegmatis was inoculated into 7H9 broth and the OD600 was measured every 3 


























3.2 MIC and MBC of antibiotics 
 
The concentration that prevented visible growth was taken as the MIC. Gath-
ering data from the MIC, the minimum bactericidal concentration (MBC) of 
the drug was also determined. This concentration is ascertained by survival 
information obtained upon plating bacterial cultures exposed to inhibitory or 
greater than inhibitory drug concentrations. The MBC was determined as the 
concentration that killed 99 % of the exposed bacterial population.   
  






































Table 1: Minimum inhibitory concentrations and Minimum bactericidal con-
centrations of the antibiotics used in the study. The MIC are comparable to 
those obtained in a). (Li, Zhang, & Nikaido, 2004) b). (Guille-




3.3   Flow cytometry to detect hydroxyl radicals 
 
3.3.1    Optimization 
Kohanksi et. al (2007) use the dye HPF to capture hydroxyl radicals at 1 
hours, 2 hours and 3 hours post drug addition and analysis by flow cytometry. 
Before testing the hydroxyl radical hypothesis for Mycobacteria, we repro-
duced their results with E. coli treated with ofloxacin and kanamycin. We no-
ticed that these drugs did indeed produce hydroxyl radicals at 3 hours post 
drug exposure. (Refer appendix) 
In order to illustrate this pathway in Mycobacteria, it was required to deter-
mine optimum dye concentration, drug concentration and precise time point 
for radical measurement. 
 
3.3.2    Dye Concentration 
As per the protocol stated in Kohanski et al. (2007), 5µM HPF was used to 
capture hydroxyl radicals and analyses by flow cytometry. However, no dif-
ference in signal was observed between the stained and unstained no-drug 
controls. Subsequently, the protocol stated in Kohanski et al. (2008) was 
adopted where in 10µM HPF was used to carry out experiments. We believe 
that a higher dye concentration was required to cross the mycolic acid rich cell 







3.3.3     Drug concentration 
Drug concentrations ranging from 0.2 to 5 times the minimum inhibitory con-
centrations were tested to assess for hydroxyl radical production. This range 
included cidal concentrations for most drugs.  
 
3.3.4     Buffer 
After treating the cells with HPF, the cells were spun down and resuspended in 
phosphate buffer saline (PBS) and analysed by flow cytometry. However, 
since mycobacterial cells clump, they blocked the channel of the flow cytome-
ter. Consequently, phosphate buffer + 0.05% tween was used to resuspend the 
cells. 
 
3.3.5     Flow cytometer settings 
All data were collected using Beckman Couter Cyan
TM
 ADP Analyser with a 
488nm argon laser and a 515-545nm FL1 emission filter.  Atleast 20,000 cells 
were analysed at medium flow rate for each sample.  
 
3.3.6     Time point: 
Optimization: Assess the activation of pathway in Mycobacterium 
smegmatis using H2O2. 
The assay was optimized using H2O2 to assess the production of hydroxyl rad-
icals in Mycobacteria. Different concentrations of H2O2 were applied, and 10
6 
cells were collected and treated with HPF at 5 minutes, 2 hours and 3 hours 
post H2O2 application and measured for increase in fluorescence. The increase 
in (mean) fluorescence is observed by a shift to higher intensity compared to 
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the control cells (untreated cells) on the histogram. Subsequently, bacterial 
cultures exposed to H2O2 concentration that resulted in hydroxyl radicals were 
treated with fenton reaction inhibitors, thiourea and dypridyl, and observed for 
inhibition of radical production correlating cell death. 
 Cell cultures treated with 1mM, 2.5mM, 12.5mM and 20mM H2O2 showed no 
increase in fluorescence 5minutes post treatment. At 2 hours and 3 hours post 
treatment, cells treated with 20mM H2O2 showed an increase in fluorescence 
(Figure 4). 3 hours was taken as the optimal time point for measuring hydroxyl 
radicals from cells treated with 20mM H2O2.                                                                              
Figure 5 illustrates the treatment with fenton inhibitors. Sub-inhibitory con-
centrations of fenton inhibitors, dypridyl (0.1mM) and thiourea (60µM) were 
added to cells 5 minutes prior to addition of 20mM H2O2. Thiourea, as indi-
cated by cell survival and histogram prevented radical formation and cell 
death. Neither cell death nor radical production was prevented by dypridyl. On 
the contrary, dypridyl caused a boost in hydroxyl radicals, at intensity much 






Figure 4: Log phase cultures of M. smegmatis were exposed to different concen-
trations of H2O2 and assessed for hydroxyl radicals at 2 hours and 3 hours post 
application. At 2 hours no hydroxyl radicals were produced as shown by the his-
togram on the left. At 3 hours post H2O2 application, 20mM H2O2 showed a 
spike in hydroxyl radicals as indicated by the arrow head in the histogram on 
the right.The histograms from one of the three experiments performed are 
shown above.                       
T2: 2 hours post H2O2 application; T3: 3 hours post H2O2 application.     
Figure 5: Log phase cultures of M. smegmatis were tested for the inhibition of fen-
ton reaction. Hydroxyl radical quencher, thiourea (60µM) and iron chelator, 
dypridyl (0.1mM) were added to two independent cultures prior to H2O2 treatment, 
while another culture was treated with H2O2 alone. The histogram from one the 
three experiments performed is presented, showing the fenton inhibition by 
thiourea at 3 hours post treatment with 20mM H2O2.  Dypridyl+ H2O2 treated cul-
tures produced more hydroxyl radicals (blue arrow head) than by only H2O2 treated 
cultures (black arrow head).  The corresponding CFU (right) of three independent 
experiments performed in duplicates shows a 100 fold increase in survival by 
thiourea addition, but no cell death rescue by dypridyl. Student’s t-test, p-value < 
0.005; T3: 3 hours post H2O2 exposure.                 
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Optimization: Assess the activation of the pathway in Mycobacterium 
smegmatis using the fluoroquinolone, ciprofloxacin 
The main objective was to determine if drug treatment of mycobacterium gen-
erated hydroxyl radicals. Cell cultures were treated with 0.4µM ciprofloxacin 
(½xMIC), 0.8µM ciprofloxacin (1xMIC) and 1.6µM ciprofloxacin (2xMIC) 
and 10
6
 cells were collected at 4 hours, 9 hours and 24 hours post drug appli-
cation for hydroxyl radical measurement. These time points were chosen as 
drugs take a longer time to produce their effects. At 4 hours and 9 hours post 
drug treatment, no hydroxyl radicals were observed (Figure 6 and 7). At 24 
hours post treatment, all the three concentrations of ciprofloxacin showed a 
spike in hydroxyl radicals and a decrease in cell survival (Figure 8). While 
0.4µM ciprofloxacin showed a 100 fold decrease in survival,   0.8µM ciprof-
loxacin and1.6µM ciprofloxacin reduced the colony forming capacity by 
10000 and 100000-fold respectively. At the MIC of 0.8µM ciprofloxacin, fen-
ton inhibitors dypridyl and thiourea were added to assess the decrease in hy-
droxyl radicals. As expected, sub inhibitory concentrations of fenton inhibitors 
decreased radical formation and prevented cell death (Figure 9). Dypridyl 
(0.1mM) produced a near 1000 fold increase in survival while thiourea 
(60µM) produced a 10 fold increase in survival compared to cells treated with 
ciprofloxacin alone.  Graphs showing the relative fluorescent intensity (rela-
tive to the stained control) and the difference between the stained and un-
stained internal samples control were also plotted using GraphPad Prism 6 
(Figure 12). An antibiotic is classified as a hydroxyl radical inducing one only 
if the result is positive by all the three methods of analysis namely (i) the Rela-
tive fluorescence intensity (RFI) (ii) the data showing the difference between 
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stained and unstained internal sample controls and (iii) the histogram (which 
indirectly shows the mean fluorescence intensity (MFI)).   
 
RFI(%) is calculated by the formula:  
MFI of the stained antibiotic treated sample - MFI control stained 
                                          MFI control stained 
 
 
The stained v/s unstained is calculated by subtracting the mean fluorescence 
of the unstained samples from the corresponding stained samples.  
  
  The three methods of estimating fluorescence indicate that upon ciprofloxa-
cin treatment, hydroxyl radicals are formed (at 24 hours post drug addition) 
via the fenton reaction and survival measurements indicate that their produc-
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Figure 6: Log phase cultures of M. smegmatis were treated with 0.4µM,  
0.8µM and 1.6µM ciprofloxacin and assessed for hydroxyl radicals at 4 hours 
post treatment. On the left, the histogram obtained from one of the three ex-
periments performed is presented, showing that, no hydroxyl radicals were 
produced at this time point. The corresponding CFU of 3 independent exper-
iments performed in duplicates is shown on the right.                                              
Student’s t-test, *p-value< 0.05 ;    ** p-value< 0.005 
 
 
Figure 7: Log phase cultures of M. smegmatis were treated with 0.4µM, 
0.8µM and 1.6µM ciprofloxacin and assessed for hydroxyl radicals at 9 
hours post treatment. On the left, the histogram obtained from one of the 
three experiments performed is presented, showing that, no hydroxyl radicals 
were produced at this time point. The corresponding CFU of 3 independent 
experiments performed in duplicates is shown on the right. 0.8µM ciproflox-
acin and 1.6µM ciprofloxacin produce a 10 fold and a 100 fold kill respec-






















































    



















































Figure 8: Log phase cultures of M. smegmatis were treated with 0.4µM, 
0.8µM and 1.6µM ciprofloxacin and assessed for hydroxyl radicals at 24 
hours post treatment. On the left, the histogram obtained from one of the 
three experiments performed is presented, showing that, all the concentra-
tions of ciprofloxacin applied produced hydroxyl radicals at this time point 
as shown by the arrow heads. 1.6µM ciprofloxacin shows a tailing popula-
tion of cells with increased fluorescence (red arrow head). The corre-
sponding CFU of 3 independent experiments performed in duplicates is 
shown on the right. 0.4µM ciprofloxacin produces a 100 fold kill while 
0.8µM ciprofloxacin and 1.6µM ciprofloxacin produce a 10000 fold and a 
100000 fold kill respectively. Student's t-test, p-value< 0.05 
Figure 9: Log phase cultures of M. smegmatis were tested for the inhibition 
of fenton reaction. Hydroxyl radical quencher, thiourea (60µM) and iron 
chelator, dypridyl (0.1mM) were added to two independent cultures prior to 
treatment with 0.8µM ciprofloxacin, and one culture was treated with 0.8 µM 
ciprofloxacin alone. On the left, the histogram obtained from one of the three 
experiments performed is presented, showing that dypridyl and thiourea pre-
vented ciprofloxacin induced OH˙(black arrow head). The corresponding 
CFU from 3 independent experiments performed in duplicates is shown on 
the right. Thiourea produces a 10 fold rescue while dypridyl provides a near 
complete rescue. Student's t-test, p-value< 0.05 
TU: thiourea;   Dyp: dypridyl 
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3.4 Assess hydroxyl radical production in response to treatment with oth-
er fluoroquinolones.  
The production of hydroxyl radicals in response to other fluoroquinolones 
namely sparfloxacin, levofloxacin and ofloxacin and were also assessed. At 9 
hours, like ciprofloxacin, the other fluoroquinolones, at their MIC concentra-
tions showed no increase in hydroxyl radicals (Figure 10). Figure 11 shows 
the hydroxyl radical production at 24 hours with the corresponding survival 
measurements. Subsequently, the graphs showing the relative fluorescence 
intensity and the difference between the stained v/s unstained were also plot-
ted (Figure 12). Taken together, the analyses show that, sparfloxacin, 
levofloxacin and ofloxacin produce hydroxyl radicals which results in cell 
death. 
 




































Figure10: Log phase cultures of M. smegmatis were treated with MIC con-
centrations of levofloxacin, sparfloxacin and ofloxacin and assessed for hy-
droxyl radicals at 9 hours post drug application. On the left, the histogram 
obtained from one of the three experiments performed is presented, showing 
that, none of the drugs produced OH˙ at this time point. The corresponding 
CFU obtained over 3 independent experiments performed in duplicates is 
shown on the right. Levofloxacin produces about a 10 fold kill while 
sparfloxacin and ofloxacin produce a 1000 fold kill at 9 hours. Student’s t-
test, p-value< 0.005. 
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Figure 12: Log phase cultures of M. smegmatis were treated with MIC concen-
trations of ciprofloxacin, levofloxacin, sparfloxacin and ofloxacin and assessed 
for hydroxyl radicals at 24 hours post drug application. Relative fluorescence 
intensity (RFI %) is shown on the right and it indicates an increase in fluores-
cence upon fluoroquinolone treatment. On the left, the data representing the 
difference between the stained and unstained values obtained at 24h show that 
upon applying suitable unstained internal controls for each sample, a clearer 
result indicating increased fluorescence with fluoroquinolone treatment is seen.  
The data is the representation of 3 independent experiments performed in du-
plicates. Student’s t-test, *p-value< 0.05 ** p-value< 0.005. RFI: relative fluo-
rescence intensity. 
Figure 11: Log phase cultures of M. smegmatis were treated with MIC concen-
trations of levofloxacin, sparfloxacin and ofloxacin and assessed for hydroxyl 
radicals at 24 hours post drug application. On the left, the histogram obtained 
from one of the three experiments performed is presented, showing that the 3 
drugs produced OH˙ at this time point as indicated by the arrow head. The cor-
responding CFU obtained over 3 independent experiments performed in dupli-
cates is shown on the right. Levofloxacin, sparfloxacin and ofloxacin produce a 
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3.5 Hydroxyl radicals in response to Isoniazid, Ethambutol and Kanamy-
cin.  
Different concentrations of Isoniazid, Ethambutol and Kanamycin were ap-
plied to cell cultures and hydroxyl radicals were assessed at 9 hours and 24 
hours post drug application.  Subsequently, the relative fluorescent intensity 
and the stained v/s unstained were calculated which are shown below.  
 
3.5.1 Isoniazid treatment 
 Cell cultures were treated with 5 different concentrations of Isoniazid ranging 
from 1/5
th
 of the minimum inhibitory concentration to 5 times the minimum 
inhibitory concentration. We were looking for identical results from our analy-
sis to conclude that a drug induced hydroxyl radicals. However, at all concen-
trations of isoniazid, we observed inconsistencies in our results. Results from 
one method of analysis were statistically significant, while from the other, 
they were not. Also, some of our results were not statistically significant by 
both the methods. This led us to conclude that Isoniazid does not produce hy-
droxyl radicals in M. smegmatis. The relative fluorescence intensity and the 
stained v/s unstained data along with the corresponding CFU are shown below 
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Figure 13: Log phase cultures of M. smegmatis were treated with isoniazid con-
centrations ranging from 1/5th MIC to 5MIC and assessed for OH˙ at 9 hours 
and 24 hours post drug application.  At 9 hours:(i) The RFI is on the negative 
end. (ii) No statistically significant difference is observed between the stained 
and unstained internal controls. (iii) 1/5 MIC,1/2 MIC, MIC and 2MIC kill 10 
fold, while 5MIC kills 100 fold.  At 24 hours: (iv)There is an increase in RFI at 
MIC, 2MIC and 5MIC. (v) A statistically significant difference between the 
stained and unstained internal control is observed only for 2MIC and 5MIC. 
(vi)1/5 MIC and ½ MIC kill 10 fold, MIC kills 100 fold, while 2MIC and 5MIC 
kill 1000 fold. The data shown is obtained over 3 independent experiments per-
formed in duplicates. Student’s t-test,*p-value<0.05, **p-value<0.005;           
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3.5.2 Kanamycin treatment: 
E. coli produces hydroxyl radicals in response to kanamycin. This is observed 
in the Kohanski study and by us during our assay development experiments. 
Since, Kanamycin is a second line injectable used in Tb therapy, we treated  
M. smegmatis with 5 different concentrations of kanamycin ranging from 1/5
th 
 
of the minimum inhibitory concentration to 5 times the minimum inhibitiory 
concentration. Surprisingly, even cidal concentrations of Kanamycin (5µM 
and 12.5µM) did not produce any hydroxyl radicals. The RFI showed a slight    
increase for sub inhibitory concentrations of kanamycin while at 24h the rela-
tive fluorescence was at the negative end. Figure 14 shows the RFI, stained v/s 
unstained and the corresponding CFU at 9 hours and 24 hours post drug appli-
cation. We were looking for identical results from our analysis to conclude 
that a drug induced hydroxyl radicals. However, at all concentrations of kan-
amycin, data analysis showed that the results were inconsistent. Results from 
one method of analysis were statistically significant, while from the other, 
they were not. Also, some of our results were not statistically significant by 
both the methods. Taking this together, we conclude that contrary to E. coli, 










3.5.3 Ethambutol treatment: 
We tested Ethambutol at minimum inhibitory and higher than minimum inhib-
itory concentrations to check for the production of hydroxyl radicals. We were 
looking for identical results from our analysis to conclude that a drug induced  
hydroxyl radicals. However, at all concentrations of ethambutol, data analysis 
showed that the results were inconsistent. Results from one method of analysis 
were statistically significant, while from the other, they were not. Also, some 
of our results were not statistically significant by both the methods. This led us 
to conclude that M. smegmatis does not produce hydroxyl radicals in response 
to Ethambutol (Figure 15).
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Figure 14: Log phase cultures of M. smegmatis were treated with kanamycin 
concentrations ranging from 1/5th MIC to 5MIC and assessed for OH˙ at 9 
hours and 24 hours post drug application. At 9 hours: (i) The RFI is on the 
negative end for MIC, 2MIC and 5MIC. (ii) A statistically significant difference 
between stained and unstained internal control is observed only for MIC. (iii) 
There is a near 10000 fold and 100,000 fold kill at 2MIC and 5MIC respective-
ly.  At 24 hours: (iv)The RFI is on the negative end. (v) No statistically signifi-
cant difference is observed between stained and unstained internal controls. (vi 
)There is a near 10 fold kill at ½ MIC, 10 fold kill at MIC, a near 107fold kill at 
2MIC, and at 5MIC no colonies are obtained. The data shown is obtained over 
3 independent experiments performed in duplicates. Student’s t-test, *p-
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Figure 15: Log phase cultures of M. smegmatis were treated with ethambutol 
concentrations ranging from MIC to 5MIC and assessed for OH˙ at 9 hours 
and 24 hours post drug application.  At 9 hours: (i) The RFI is on the negative 
end and (ii) The difference between stained and unstained internal control is 
statistically significant only for MIC. (iii) There is a 10 fold kill at 2MIC and 
5MIC. At 24 hours: (iv)The relative fluorescence is on the negative end for all 
except for 5MIC (v) No statistically significant difference is observed between 
the stained and unstained internal controls.  (vi) There is a 10 fold kill at MIC 
while at 2MIC, and at 5MIC, a near 100 fold kill is observed. The data shown is 
obtained over 3 independent experiments performed in duplicates. Student’s t-
test, *p-value<0.05, **p-value<0.005; RFI: Relative fluorescence intensity.       
* 
** 










Mycobacterium smegmatis is a non-pathogenic surrogate to conduct tubercu-
losis studies. Working with the pathogen, Mycobacterium tuberculosis itself 
involves several containment and biosafety issues, and could pose as a danger 
to the working individual. Mycobacterium smegmatis, a saprophyte of the 
same genus is an established working model for several reasons mentioned 
earlier. However, the two organisms differ from each other on a number of 
levels. For one, an obvious difference is the generation time. The doubling 
time is 3 hours in Mycobacterium smegmatis, while Mycobacterium tubercu-
losis requires nearly one whole day. This difference has been attributed to sev-
eral genetic traits that M. smegmatis possesses, while M.tb doesn’t.  
 However, the inherent saprophytic nature of M. smegmatis and the persistent 
pathogenic ability of M. tb, poses as the most obvious difference. Being a sap-
rophyte, M. smegmatis cannot enter epithelial cells and persist in phagocytes 
like M. tb. The genetic cause for this is yet to be found out (Long et al., 2012).  
However, the benefits of using M. smegmatis (as a TB surrogate) have out-
weighed the disadvantages. Though studying results performed on the model 
organism can be very different from performing them on the pathogenic bacte-
ria, and results can puzzle scientists who are analysing and interpreting data 
(Long et al., 2012), using the bacteria easily for performing preliminary work 
has been unanimously accepted. The ability to manipulate the bacteria accord-
ing to the researchers needs stands as the biggest advantage and helps build 
the knowledge resource for Tb drug development.  
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For the very same reasons, M. smegmatis was adopted as our study model to 
detect if the cell death pathway proposed by Kohanski (2007) for E. coli and   
S. aureus is also traced by the distinctive group of Mycobacteria. In summary, 
Kohanski and colleagues found that the different classes of antibiotics interact 
with their targets and change the internal environment of the cell such that, 
highly toxic chemical species such as the hydroxyl radicals are formed via the 
fenton reaction, at an amount the cell is incapable of withstanding. The radi-
cals are involved in disrupting various cellular entities, especially the DNA. 
This causes cell death irrespective of the target (of the drug), as long as the 
concentration of the drug applied is cidal. 
 
The common pathway triggered in Mycobacterium smegmatis 
Adopting the Kohanski (2008) protocol, we tested if hydrogen peroxide, a par-
ticipant in the fenton reaction, could drive the reaction and result in the pro-
duction of hydroxyl radicals detectable by hydroxyl radical specific dye, HPF. 
The primary objective to establish the assay with H2O2 was to determine if 
Mycobacteria could activate such a response at all. We chose time points that 
were close to the time of hydrogen peroxide application due to its immediate 
reactivity and effects. We tested different concentrations of H2O2 at 1 hour, 2 
hours and 3 hours post addition and 20mM H2O2 produced the required re-
sponse. This effect being reproducible, the reaction was tested for specificity 
of the dye. Hydroxyl radical quencher, thiourea was able to quench hydroxyl 
radicals and also rescue cells from death caused by H2O2 application. Howev-
er, the iron chelator, dypridyl was unable to prevent hydroxyl radical for-
mation and surprisingly caused an increase in hydroxyl radical production. 
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The reasons for the failure of the iron chelator, dypridyl, to prevent hydroxyl 
radicals generated upon H2O2 treatment are unclear, and this appears to be an 
H2O2 specific phenomenon as the chelator successfully blocked drug induced 
radical production (see below). It is to note that concentration of 0.1mM 
dypridyl used in the study is sub-inhibitory.   
 
Treatment with fluoroquinolones results in hydroxyl radicals via the 
common pathway. 
After developing the hydroxyl radical detection assay with H2O2, we initiated 
our analysis using ciprofloxacin, a fluoroquinolone. We used a range of con-
centrations around the MIC to test for hydroxyl radicals and cell death. We 
observed that all concentrations of ciprofloxacin used produced hydroxyl radi-
cals at 24 hours post drug application. At these concentrations, it was observed 
that there was a decrease in colony forming capacity at 24 hours, thus indicat-
ing that the hydroxyl radicals were involved in causing cell death. In particu-
lar, 0.4µM ciprofloxacin (1/2 MIC)  and 0.8µM ciprofloxacin (MIC) produces 
a 100 fold and 10000 fold kill respectively, but both the concentrations pro-
duced more or less the same amount of hydroxyl radicals as indicated by the 
MFI (MFI values not shown) and the histogram (Figure 8).  However, 1.6µM 
ciprofloxacin shows the least MFI value (MFI values not shown) and thus the 
least shift in fluorescence intensity on the histogram compared to the other two 
concentrations. This is probably because at this concentration, far too many 
cells die by the 24 hour time point (100000 fold kill). We further tested the 
inhibition of hydroxyl radicals using radical scavenger, thiourea, and iron 
chelator, dypridyl which were added to cell cultures 5-10 minutes prior to 
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treatment with 0.8µM ciprofloxacin. Addition of thiourea and dypridyl pre-
vented hydroxyl radical formation and increased cell survival. Thiourea pro-
duced a 10 fold increase in cell survival, while dypridyl nearly rescued cells 
from death. Taken together, these experiments suggest that ciprofloxacin in-
duces hydroxyl radical production and that the hydroxyl radicals generated are 
involved in the cidal activity of this fluoroquinolone.  
 
We further tested the production of hydroxyl radicals for 3 other drugs from 
the same class of fluoroquinolones to both validate and consolidate the 
fluoroquinolone effect. Cell cultures treated with MIC concentrations of the 
levofloxacin, sparfloxacin and ofloxacin were analysed for hydroxyl radicals. 
It was found that all the four quinolones (including ciprofloxacin) produced 
comparable amount of hydroxyl radicals at 24 hours post drug application. 
This, we can reason, is a consequence of applying ‘same effect’ (‘minimum’ 
inhibitory) concentration. The three methods of data analysis (Histogram as an 
indicator of mean fluorescence intensity (MFI), relative fluorescence and de-
termining stained v/s unstained fluorescence) being statistically significant as-
serts that fluoroquinolones indeed do produce hydroxyl radicals at 24 hours 
post drug application. The production of hydroxyl radicals by the 
fluoroquinolones was also assessed at 9 hours post drug application. At 9 
hours, despite significant cell death observed upon application of certain con-
centrations of the drugs, no hydroxyl radicals were detected by the probe. This 
lack of co-relation between the cidal effect of the antibiotic(s) and the produc-
tion of hydroxyl radicals should be explored by performing DNA damage and 
supporting biochemical assays. This will also enable us to look into the relia-
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bility of using the probe to perform such assays (see below for a section cov-
ered on probe reliability).         
 
Our studies with the fluoroquinolones indicate that the cidal MIC concentra-
tions of fluoroquinolones cause hydroxyl radical mediated cell death in Myco-
bacterium smegmatis also, as first described by Kohanksi et al. (2007) for E. 
coli and S. aureus. However, this preliminary data has to be supplemented 
with analysis on DNA damage and cellular NADH levels to strengthen the da-
ta regarding the adherence of these drugs to the common pathway (Kohanksi 
et al., 2007).        
  
M. smegmatis treated with isoniazid, kanamycin, and ethambutol.  
The 3 drugs tested other than the fluroroquinolones, did not significantly in-
duce hydroxyl radicals. For the three drugs, isoniazid, kanamycin and 
ethambutol, we observed inconsistencies in our results obtained from the three 
methods of analysis (Histogram showing the MFI, RFI, stained v/s unstained 
data values). As mentioned before, the results being statistically significant by 
all the three methods was essential to ‘label’ a drug as ‘hydroxyl radical induc-
ing’. However, data analysis showed that at all concentrations of isoniazid, 
kanamycin and ethambutol applied, this criterion was not satisfied. 
  Therefore, contrary to the results found with E. coli (Kohanksi et. al., 2007), 
the probe HPF was unable to detect hydroxyl radicals produced in Mycobacte-
rium smegmatis at both 9 hours and 24 hours post treatment with drug, kana-
mycin. The probe was also unable to detect hydroxyl radicals produced by     
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M. smegmatis treated with anti-mycobacterial drug, isoniazid and ethambutol 
at 9 hours and 24 hours post drug treatment.   
  
The increase in hydroxyl radicals upon drug treatment is observed in the his-
togram by a shift to the higher intensity, which directly corresponds to the flu-
orescence measured by the detector. Mycobacterium smegmatis, when ex-
posed to fluoroquinolones seems to produce relatively less hydroxyl radicals 
compared to E. coli.  However, the intensity of hydroxyl radical production       
(measured as fluorescence) induced by fluroroquinolones in M. smegmatis is 
comparable to experiments performed on S. aureus by Kohanski et al (2007).  
  
It is possible that Mycobacterium smegmatis produces larger quantities of rad-
icals than observed/detected in this study. Due to the short half of the hydroxyl 
radicals, it is possible that we have not assessed them at their exact time of 
production and conducting kinetic experiments would help to probe into that 
problem. Another issue could also be cell penetration ability of the hydroxyl 
radical probe. The thick mycolic acid rich cell wall could hinder its entry into 
cells and thus we observe reduced hydroxyl radical production.  To determine 
whether the cell penetration ability of the probe is different in Mycobacteria 
compared to other bacteria, cell uptake assays need to be performed. This will 
help us to establish the reliability of using the probe to conduct studies in My-
cobacteria.   
 
Understanding oxidative damage and its effects on cell survival was central to 
our study. More specifically, our aim was to explore if antibiotics induce oxi-
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dative damage in M.smegmatis and if this leads to cellular death. However, we 
also explored the cidal activity of different concentrations hydrogen peroxide, 
an established oxidative-damage inducing agent. In order to study oxidative 
damage, besides hydrogen peroxide, agents such as paraquat, t-butylated hy-
drogen peroxide, cumene hydroperoxide, xanthine–xanthine oxidase, 
plumbagin, etc can also be used (Sigler, Chaloupka, Brozmanova, Stadler & 
Hoffer, 1999).  
 
The common death pathway is driven by increased respiration which occurs 
due to drug binding (Kohansky et al., 2007).However, exposing bacteria to 
high concentrations of oxygen could be other means of driving or increasing 
respiration and inducing reactive oxygen species. Hyperbaric oxygen therapy 
(HBOT) has been used in the treatment of various infectious diseases and the 
principle behind this process underlines our hypothesis. Hyperbaric oxygen 
therapy can be bacteriostatic or bactericidal depending upon the duration and 
the pressure at which the therapy is administered (Widiyanti, 2011).  It has 
been used in the treatment of diseases such as necrotizing fasciitis 
(Riseman, Zamboni,  Curtis,  Graham,  Konrad &  Ross, 1990)  and (spinal) 
tuberculosis (Topuz, Kutlay, Şimşek, Çolak,  Kaya  &  Demircan, 2009) and 
in both cases co-administering HBOT with surgical and/or drug treatment im-
proved the results of treatment. There have also been researches conducted on 
using oxygen as an antibiotic that can be used along with other conventional 
antibiotics for treating dermal infections (Knighton, Halliday & Hunt, 1984).   
 There has been research demonstrating ‘heat-shock’ to be another way to in-
crease respiration and to produce radical species. Heat shock induced oxida-
54 
 
tive stress has been shown in organisms such as Saccharomyces cerevisiae  
(Davidson, Whyte, Bissinge  &  Schiestl, 1996), Aspergillus niger 
(Abrashev,  Pashova,  Stefanova,  Vassilev,  Dolashka-Angelova &  Angelova, 
2008) and even E. coli (Privalle & Fridovich, 1987). Further research needs to 
be conducted to explore the dynamics of these processes in Mycobacteria and 
other organisms. 
   
There is also a possibility that M. smegmatis might initiate programmed cell 
death upon exposure to stress (antibiotic) such as the MazEF pathway charac-
terised in E. coli. The MazEF system is a toxin-antitoxin system encoded in 
the chromosome where in MazE is a labile anti-toxin while MazF is a stable 
toxin. Under normal conditions, MazE inhibits the action of MazF. Under 
stress, the toxin MazF is induced and large populations of cells die in a ROS 
dependent or independent manner. This is believed to be an altruistic mecha-
nism of cell survival via quorum sensing as cells are sacrificed in order to al-
low a small population of cells to thrive when favorable conditions return. 
However, E. coli also outlines a-selfish mode of survival whereupon individu-
al cells repair their DNA to try and outlive stressful conditions. This is known 
as the apoptotic like death (ALD) pathway (Erental, Sharon, & Engelberg-
Kulka, 2012).  Complicated as these are, these mechanisms might be em-
ployed by bacteria to evade the constant pressure we are imposing through the 
means of antibiotics and the mycobacterial species might well employ such 
convoluted mechanisms to survive. Thus, additional studies looking into such 
pathways might just be worthwhile to pursue.  
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The impetus for exploring such cell death pathways is to understand bacterial 
responses to antibiotic induced stress. Research teams over the world have 
taken up the different approaches to comprehend cell survival techniques and 
cell death pathways to make antibiotics that could outlast bacterial recovery 
mechanisms. While some teams such as ours seek out to do a step by step 
analysis of bacterial responses, other teams have alternatively tried to under-
stand quorum sensing and finding ways to silence and tame bacteria such that 
they cease to be pathogenic. It seems to be worthwhile to invest time, energy 
and manpower in such studies that could generate a knowledge resource which 




5.  Conclusion 
 
 
The threat of antibiotic resistance has provided the right stimulus to explore 
bacteria. ROS induced cell death has been a fascinating area for scientists and 
developing antibiotics specific to bacterial targets that could trigger reactive 
oxygen intermediates is an enticing idea. Thus, the study by Kohanski et al. 
(2007) was groundbreaking and revolutionary in its own right and evaluating 
this pathway in other bacteria is an important area of research.  
    
In the present study, we have developed an assay to detect the deleterious hy-
droxyl radicals produced in Mycobacterium smegmatis. Our study indicates 
that the applied cidal concentrations of fluoroquinolones trigger a common 
cell death pathway that produces significant amounts of hydroxyl radicals that 
causes bacterial cell death. However, hydroxyl radical induced death can be 
prevented, in vivo, by the application of fenton reaction inhibitors. The fenton 
inhibitors, thiourea and dypridyl prevent the formation of hydroxyl radicals 
upon ciprofloxacin treatment thereby increasing cell survival. On the other 
hand, contrary to the Kohanski study, cidal concentrations of drugs kanamy-
cin, isoniazid and ethambutol did not induce hydroxyl radicals. This suggests 
that in contrast to E. coli and S. aureus, not all cidal drugs kill via the genera-
tion of hydroxyl radicals. Mycobacteria, in contrast to Gram positive and 
Gram negative bacteria appear to illustrate hydroxyl radical dependent as well 
as independent cell death pathways.   
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6.  Future  work 
 
Since only a few of the mycobacterial drugs were tested in the study, it is re-
quired to test the entire Tb-drug bank to define which drugs induce the com-
mon death pathway in mycobacteria and which drugs don’t. To complement 
data obtained from the primary end point (hydroxyl radical detection), DNA 
damage and biochemical assays need to be performed to get a more compre-
hensive picture on the involvement of common pathway in drug-induced cell 
death. Evidently, these studies should also be performed with the BSL3 patho-
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Figure 16: The experiment was conducted to replicate the findings by 
Kohanski (2007). Log phase cultures of E. coli were treated with 250ng/mL 
ofloxacin and assessed for hydroxyl radicals at 3 hours post drug application. 
The orange curve indicated by the black arrow head on the histogram shows a 
shift to higher fluorescence intensity thereby indicating the production of hy-
droxyl radicals as detected by the probe. The samples were collected using BD 
FACS Calibur flow cytometer with a 488 nm argon laser and a 515–545 nm 
emission ﬁlter(FL1) at low ﬂow rate. Atleast 50,000 events were collected for 




Figure 16: The experiment was conducted to replicate the findings by 
Kohanski (2007). Log phase cultures of E. coli were treated with 5µg/mL 
kanamycin and assessed for hydroxyl radicals at 3 hours post drug applica-
tion. The orange curve indicated by the black arrow head on the histogram 
shows a shift to higher fluorescence intensity thereby indicating the produc-
tion of hydroxyl radicals as detected by the probe. The samples were collected 
using BD FACS Calibur flow cytometer with a 488 nm argon laser and a 
515–545 nm emission ﬁlter(FL1) at low ﬂow rate. Atleast 50,000 events were 
collected for each sample. PMT voltage settings used: E00 (FSC), 360 (SSC), 
825 (FL1).  
